Market Cap 23.38M
Revenue (ttm) 316.61M
Net Income (ttm) 35.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 11.26%
Debt to Equity Ratio 0.28
Volume 501
Avg Vol 7,928
Day's Range N/A - N/A
Shares Out 12.99M
Stochastic %K 82%
Beta 0.83
Analysts Strong Buy
Price Target $17.00

Company Profile

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a read...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 201 326 5300
Address:
50 Tice Boulevard, Suite 315, Woodcliff Lake, United States
honestinvt7672
honestinvt7672 Jan. 25 at 7:50 AM
$EGRX Time bomb!-https://academic.oup.com/ofid/article/13/Supplement_1/ofaf695.1411/8421474
0 · Reply
11thestate
11thestate Jan. 16 at 2:43 PM
$EGRX has agreed to settle with investors over claims that it misled them about product performance, revenue reporting, and internal financial controls related to its cancer drug PEMFEXY. Who’s eligible? Anyone who purchased $EGRX shares between August 9, 2022 and October 1, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share has not been determined yet. Can I still file? Claim availability depends on the settlement administrator’s approval process. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/eagle-investor-suit
0 · Reply
Biocuda
Biocuda Jan. 8 at 10:40 PM
$EGRX coming up soon January 14, 2026 – PDUFA goal date noted for EA-114 review
1 · Reply
11thestate
11thestate Jan. 6 at 2:49 PM
$EGRX investors — there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Dec. 23 at 2:59 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $EGRX investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Dec. 11 at 3:31 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Nov. 26 at 3:37 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
Biocuda
Biocuda Oct. 30 at 5:41 PM
$EGRX it’s funny that Tarriff had to sue eagle to hold the annual shareholder meeting since they haven’t had one since 2023. You would think they know what the law is. https://www.law.com/radar/card/de-na-545898-tariff-v-eagle-pharmaceuticals-inc
1 · Reply
11thestate
11thestate Oct. 30 at 2:01 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
tdappello
tdappello Oct. 17 at 8:01 PM
$EGRX what is going on here?
0 · Reply
Latest News on EGRX
No data available.
honestinvt7672
honestinvt7672 Jan. 25 at 7:50 AM
$EGRX Time bomb!-https://academic.oup.com/ofid/article/13/Supplement_1/ofaf695.1411/8421474
0 · Reply
11thestate
11thestate Jan. 16 at 2:43 PM
$EGRX has agreed to settle with investors over claims that it misled them about product performance, revenue reporting, and internal financial controls related to its cancer drug PEMFEXY. Who’s eligible? Anyone who purchased $EGRX shares between August 9, 2022 and October 1, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share has not been determined yet. Can I still file? Claim availability depends on the settlement administrator’s approval process. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/eagle-investor-suit
0 · Reply
Biocuda
Biocuda Jan. 8 at 10:40 PM
$EGRX coming up soon January 14, 2026 – PDUFA goal date noted for EA-114 review
1 · Reply
11thestate
11thestate Jan. 6 at 2:49 PM
$EGRX investors — there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Dec. 23 at 2:59 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $EGRX investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Dec. 11 at 3:31 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Nov. 26 at 3:37 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
Biocuda
Biocuda Oct. 30 at 5:41 PM
$EGRX it’s funny that Tarriff had to sue eagle to hold the annual shareholder meeting since they haven’t had one since 2023. You would think they know what the law is. https://www.law.com/radar/card/de-na-545898-tariff-v-eagle-pharmaceuticals-inc
1 · Reply
11thestate
11thestate Oct. 30 at 2:01 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
tdappello
tdappello Oct. 17 at 8:01 PM
$EGRX what is going on here?
0 · Reply
Biocuda
Biocuda Oct. 17 at 2:54 PM
$EGRX did anyone join the stockholders meeting? Anything interesting?
0 · Reply
honestinvt7672
honestinvt7672 Oct. 15 at 10:44 PM
$EGRX now is the time for Natahala and his buddies to bankrupt Egrx and take it all for themselves
1 · Reply
honestinvt7672
honestinvt7672 Oct. 12 at 6:42 AM
$EGRX Scum-Scott Tariff
1 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 18 at 1:39 AM
$EGRX audited financials published quicker than expected, when do they uplist?
3 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 18 at 1:31 AM
$EGRX $43M in operating profit and they spend $49M on R&D...
0 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 13 at 5:01 PM
$EGRX how big do you think revenues are now? I like the new board memeber
1 · Reply
honestinvt7672
honestinvt7672 Aug. 19 at 6:06 AM
$EGRX Anyone going to the Meeting? What a joke
2 · Reply
worldslargestpenguin
worldslargestpenguin Aug. 9 at 1:53 PM
$EGRX anyone a fan of this company? what's next?
1 · Reply
LeoK_Lmnt88
LeoK_Lmnt88 Jul. 23 at 3:29 PM
$EGRX ⁨ ⁨Retail traders are actively loading up WKSP suggests growing interest ahead of a potential move; watching the 4.00 level closely⁩
1 · Reply
zoomlik
zoomlik Jul. 20 at 2:30 AM
$EGRX Don’t think we can buy or sell it.
2 · Reply
mikefbi
mikefbi Jul. 18 at 1:22 AM
$EGRX Still super
0 · Reply
Luckyluciano
Luckyluciano Jul. 11 at 12:10 PM
$EGRX Why is this moving up so much on no news? Entire market going up & up & up ”just because!” Just like the real estate market used to.
0 · Reply